The final, formatted version of the article will be published soon.
ORIGINAL RESEARCH article
Front. Med.
Sec. Ophthalmology
Volume 11 - 2024 |
doi: 10.3389/fmed.2024.1534120
This article is part of the Research Topic New Concepts, Advances, and Future Trends in Clinical Research on Eye Diseases View all 14 articles
Aging-enhanced autophagy activity promotes fibrotic progression via the TGF-β2/Smad signaling pathway in trabecular meshwork cells-a new insight from POAG
Provisionally accepted- 1 Eye Center, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China
- 2 Stomatology Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, China
- 3 Institute of Immunology, Zhejiang University School of Medicine, Hangzhou, Zhejiang Province, China
Glaucoma, a leading cause of irreversible blindness, is characterized by optic neuropathy and retinopathy, with primary open-angle glaucoma (POAG) being the most prevalent form. The primary pathogenic mechanism of POAG is the elevation of intraocular pressure due to the chronic fibrosis of the trabecular meshwork (TM). Autophagy plays a key role in maintaining cellular homeostasis and is involved in the progression of fibrosis in various organs. However, the exact contribution of autophagy to fibrosis related to POAG pathogenesis remains unknown. This study reveals increased autophagic activity in tissues from POAG patients and an age-related upregulation of autophagy in healthy human TM tissues. Using chronic H2O2 treatment as an aging model, we observed autophagy induction and fibrosis in TM cells. We further examined the role of autophagy in fibrosis and found that enhanced autophagy activity promoted fibrotic progression via the TGF-β2/Smad signaling pathway.Dexamethasone-treated TM cells served as a POAG model, highlighting the enhancing role of autophagy in fibrosis. Our work casts light on the mechanism of POAG fibrogenesis and may aid in developing potential targets for clinical therapy.
Keywords: POAG, Autophagy, Aging, Trabecular Meshwork, Fibrosis
Received: 25 Nov 2024; Accepted: 30 Dec 2024.
Copyright: © 2024 Han, Wang, Shen, Cai, Wang, Wumaier, Han and Chen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Jin Han, Eye Center, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China
Ling Shen, Stomatology Hospital, School of Medicine, Zhejiang University, Hangzhou, 310003, Zhejiang Province, China
Yiting Cai, Eye Center, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China
Ailixiati Wumaier, Eye Center, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China
Wei Han, Eye Center, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China
Wei Chen, Institute of Immunology, Zhejiang University School of Medicine, Hangzhou, 310058, Zhejiang Province, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.